The FDA announced on April 2, 2014, that Hospira Inc. is recalling Propofol Injectable Emulsion due to the presence of particulate matter in the vials. The agency classified the recall as Class I.
How to tell if you have it
- Brand: Hospira
- Product: Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), For I.V. Administration, Rx Only, 20 mL vial
- NDC: 0409-4699-30
- Lot codes: 29-614-DJ, 29-615-DJ, 29-616-DJ, 29-617-DJ, 29-628-DJ, 29-629-DJ, 29-630-DJ
- Expiration date: 05/01/2015
- Quantity: 844,300 vials
The hazard
A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include American Regent Papaverine HCl Injection Recall (July 24, 2026), Liebel-Flarsheim Optiray Imaging Bulk Package-350 Recall (July 31, 2026), and Sun Pharmaceutical DOXOrubin Liposome Injection Recall (May 12, 2026).